Literature DB >> 24480806

miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes.

Pei-Shih Hung1, Hsi-Feng Tu, Shou-Yen Kao, Cheng-Chieh Yang, Chung-Ji Liu, Ting-Yun Huang, Kuo-Wei Chang, Shu-Chun Lin.   

Abstract

Oral squamous cell carcinoma (OSCC) is a prevalent malignancy worldwide. MicroRNAs are short non-coding RNAs that regulate gene expression and are crucial for tumorigenesis. Previously, we have identified that miR-31 is frequently upregulated in OSCC and that this miR-31 increase, together with downstream effector modulation, enhances oral carcinogenesis. We have identified higher levels of miR-31 expression in oral potential malignant disorder (OPMD) tissues compared with normal oral mucosa. Exogenous miR-31 and human telomerase reverse transcriptase (hTERT) expression were introduced into cultured normal oral keratinocytes (NOKs), which led to the immortalization; these lines were designated M31OK1 and M31OK3. These immortalized lines maintained the capability to undergo squamous differentiation. In addition, migration by both cell lines was attenuated by hTERT and miR-31 knockdown. M31OK1 carries a p53 gene mutation at codon 273. A serum-tolerant subline, M31OK1-D, exhibits potent anchorage-independent growth that is attenuated by knockdown of both hTERT and miR-31. miR-31-targeted factors inhibiting HIF (FIH), which upregulated vascular endothelial growth factor (VEGF), was found crucial for oral tumorigenesis. The proliferation, migration and epithelial-mesenchymal transition of M31OK1-D are associated with downregulation of FIH and upregulation of VEGF, which require miR-31 expression. High miR-31 expression is correlated with higher VEGF expression and lower E-cadherin expression in OPMD tissue. It can be concluded that miR-31 collaborates with hTERT to immortalize NOKs and that this may contribute to early stage oral carcinogenesis. The targeting of downstream factors by miR-31 may further advance the neoplastic progression of immortalized NOKs, allowing them to become malignant.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24480806     DOI: 10.1093/carcin/bgu024

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  31 in total

1.  Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.

Authors:  Federica Ganci; Andrea Sacconi; Valentina Manciocco; Renato Covello; Maria Benevolo; Francesca Rollo; Sabrina Strano; Sara Valsoni; Silvio Bicciato; Giuseppe Spriano; Paola Muti; Giulia Fontemaggi; Giovanni Blandino
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

Review 2.  The interplay of cytokine signaling and non-coding RNAs in head and neck squamous cell carcinoma pathobiology.

Authors:  Vivek Sharma
Journal:  Mol Biol Rep       Date:  2022-07-24       Impact factor: 2.742

3.  Aberrant miR-10b, miR-372, and miR-375 expression in the cytobrushed samples from oral potentially malignant disorders.

Authors:  Hsi-Feng Tu; Kuo-Wei Chang; Shu-Chun Lin; Wan-Wen Hung; Si-Hua Ji; Hsiao-Li Wu; Chung-Ji Liu
Journal:  J Dent Sci       Date:  2021-07-30       Impact factor: 3.719

4.  Exploiting salivary miR-375 as a clinical biomarker of oral potentially malignant disorder.

Authors:  Hsi-Feng Tu; Li-Han Lin; Kuo-Wei Chang; Hui-Wen Cheng; Chung-Ji Liu
Journal:  J Dent Sci       Date:  2021-09-20       Impact factor: 3.719

5.  Cancer cells corrupt normal epithelial cells through miR-let-7c-rich small extracellular vesicle-mediated downregulation of p53/PTEN.

Authors:  Weilian Liang; Yang Chen; Hanzhe Liu; Hui Zhao; Tingting Luo; Hokeung Tang; Xiaocheng Zhou; Erhui Jiang; Zhe Shao; Ke Liu; Zhengjun Shang
Journal:  Int J Oral Sci       Date:  2022-07-19       Impact factor: 24.897

6.  miR-448 downregulates MPPED2 to promote cancer proliferation and inhibit apoptosis in oral squamous cell carcinoma.

Authors:  Linhan Shen; Liu Liu; Liangyu Ge; Long Xie; Siyu Liu; Lei Sang; Tiantian Zhan; Hongwei Li
Journal:  Exp Ther Med       Date:  2016-09-05       Impact factor: 2.447

7.  Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma.

Authors:  Patricia Severino; Liliane Santana Oliveira; Flávia Maziero Andreghetto; Natalia Torres; Otávio Curioni; Patricia Maluf Cury; Tatiana Natasha Toporcov; Alexandre Rossi Paschoal; Alan Mitchell Durham
Journal:  BMC Med Genomics       Date:  2015-06-24       Impact factor: 3.063

8.  miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo.

Authors:  Li-Yin Yeh; Chung-Ji Liu; Yong-Kie Wong; Christine Chang; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Oncotarget       Date:  2015-03-20

9.  Identification of Tumor Suppressive Genes Regulated by miR-31-5p and miR-31-3p in Head and Neck Squamous Cell Carcinoma.

Authors:  Sachi Oshima; Shunichi Asai; Naohiko Seki; Chikashi Minemura; Takashi Kinoshita; Yusuke Goto; Naoko Kikkawa; Shogo Moriya; Atsushi Kasamatsu; Toyoyuki Hanazawa; Katsuhiro Uzawa
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

10.  The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions.

Authors:  Shu-Chun Lin; Chung-Ji Liu; Si-Hua Ji; Wan-Wen Hung; Ying-Chieh Liu; Sih-Rou Chang; Hsi-Feng Tu; Kuo-Wei Chang
Journal:  Clin Oral Investig       Date:  2021-08-03       Impact factor: 3.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.